| Period Ending | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 |
|---|
|
Total Revenue
|
4,474
|
7,336
|
7,574
|
11,207
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
4,474
|
7,336
|
7,574
|
11,207
| |
|
Operating Expenses |
|
Research Development | 13,762 | 12,834 | 10,914 | 13,849 |
|
Selling General and Administrative | 6,127 | 4,869 | 3,565 | 2,915 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(15,415)
|
(10,367)
|
(6,905)
|
(5,557)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (26,669) | (51,700) | (42,649) | 13,595 |
|
Earnings Before Interest And Taxes | (42,084) | (62,067) | (49,554) | 8,038 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (42,084) | (62,067) | (49,554) | 8,038 |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (42,084) | (62,067) | (49,554) | 8,038 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(42,084)
|
(62,067)
|
(49,554)
|
8,038
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(42,084)
|
(62,067)
|
(49,554)
|
8,038
|
|
0.30%